Behnood Bikdeli (@bbikdeli) 's Twitter Profile
Behnood Bikdeli

@bbikdeli

🩺investigator, #thrombosis #antithrombotic tx,🫀outcomes @BrighamWomens @harvardmed #CORE Ed @JWatch @JACCJournals @ThrombosisRese1,Alum @YaleIMed @NYPCUCVI 🎹

ID: 1184671175651123200

calendar_today17-10-2019 03:23:53

1,1K Tweet

1,1K Takipçi

332 Takip Edilen

Behnood Bikdeli (@bbikdeli) 's Twitter Profile Photo

There was a new thoughtful guideline by American College of Cardiology AHA Science for diagnosis & mgmt of #Acute #Coronary #syndromes. Kudos to Writing Committee Sunil V. Rao Michelle O'Donoghue et al. Here's my quick NEJM Group NEJM Journal Watch summary for antithrombotic therapy recs: jwatch.org/na58642/2025/0…

Thrombosis & Haemostasis, TH,TH Open (@th_journal) 's Twitter Profile Photo

🎙️ New podcast epidode with Vasculearn ! Clot, Clot, Who’s There? tinyurl.com/ym243wm8 Dr.s de Wit, Becattini & Bikdeli discuss VTE risk stratification & anticoagulation. ✔️ Anticoag. decisions ✔️ D-dimer & risk scores ✔️ Shared decision-making ✔️ What’s next ?

🎙️ New podcast epidode with Vasculearn !  

Clot, Clot, Who’s There?

tinyurl.com/ym243wm8

Dr.s de Wit, Becattini & Bikdeli discuss VTE risk stratification & anticoagulation.

✔️ Anticoag. decisions
✔️ D-dimer & risk scores
✔️ Shared decision-making
✔️ What’s next ?
Thrombosis & Haemostasis, TH,TH Open (@th_journal) 's Twitter Profile Photo

📑Navigating Anticoagulation 💊 in Ischemic Left Ventricular Aneurysms: Lessons from Cardiac 🫀MRI Read Editorial by Ashkan Hashemi and Behnood Bikdeli thieme-connect.de/products/ejour… Original Article 📰 here thieme-connect.de/products/ejour…

📑Navigating Anticoagulation 💊 in Ischemic Left Ventricular Aneurysms: Lessons from Cardiac 🫀MRI 

Read Editorial by Ashkan Hashemi  and <a href="/bbikdeli/">Behnood Bikdeli</a>  thieme-connect.de/products/ejour…

Original Article 📰 here thieme-connect.de/products/ejour…
Mattia Galli (@mattiagalli10) 's Twitter Profile Photo

Aspirin or clopidogrel monotherapy for long-term antiplatelet therapy after PCI? Prof. Patrono and I discuss the results of the SMART-CHOICE trial and critically appraise its findings in light of the broader body of evidence. EHJ Editor-in-Chief European Society of Cardiology Journals bit.ly/4lXHO8t

Aspirin or clopidogrel monotherapy for long-term antiplatelet therapy after PCI?

Prof. Patrono and I discuss the results of the SMART-CHOICE trial and critically appraise its findings in light of the broader body of evidence. 

<a href="/ehj_ed/">EHJ Editor-in-Chief</a> <a href="/ESC_Journals/">European Society of Cardiology Journals</a> 

bit.ly/4lXHO8t
World Thrombosis Day (@thrombosisday) 's Twitter Profile Photo

From Head to Toe, Take Control. Did you know that 1 in 4 people worldwide die from conditions caused by blood clots? Thrombosis is a leading cause of death—and yet, it’s often preventable with awareness and timely care. 🔗 Get involved today: worldthrombosisday.org

From Head to Toe, Take Control.

Did you know that 1 in 4 people worldwide die from conditions caused by blood clots? Thrombosis is a leading cause of death—and yet, it’s often preventable with awareness and timely care.

🔗 Get involved today: worldthrombosisday.org
JAMA Internal Medicine (@jamainternalmed) 's Twitter Profile Photo

LLM-generated discharge summaries were of comparable quality to those generated by physicians, though they contained more errors, and both types had low overall harmfulness scores. ja.ma/44XgLUC

Vasculearn Network (@vasculearn) 's Twitter Profile Photo

We're back with another exciting edition of What's Hot In Clots! 💜 This month we delve into the considerations for Factor V Leiden testing. Do we really need to test for Factor V Leiden as often as we do? 📚 A recent JAMA piece makes a strong case: in most scenarios —

Inter ⭐⭐ (@inter) 's Twitter Profile Photo

𝐂𝐇𝐀𝐌𝐏𝐈𝐎𝐍𝐒 𝐋𝐄𝐀𝐆𝐔𝐄 𝐅𝐈𝐍𝐀𝐋: ℎ𝑒𝑟𝑒 𝑤𝑒 𝑐𝑜𝑚𝑒 🔥 #ForzaInter #UCL #InterBarcellona

𝐂𝐇𝐀𝐌𝐏𝐈𝐎𝐍𝐒 𝐋𝐄𝐀𝐆𝐔𝐄 𝐅𝐈𝐍𝐀𝐋: ℎ𝑒𝑟𝑒 𝑤𝑒 𝑐𝑜𝑚𝑒 🔥

#ForzaInter #UCL #InterBarcellona
Behnood Bikdeli (@bbikdeli) 's Twitter Profile Photo

Thanks so much UVA Cardio for the opportunity to visit for #CV GrandRounds. Wonderful connecting w old friends, making new ones, & connecting w UVA Cardiology Fellowship. Look forward to further collaborations. Despite the ⛈️, Zocalo was awesome!😄Christopher Kramer MD AntonioAbbate

Thanks so much <a href="/CardioUva/">UVA Cardio</a> for the opportunity to visit for #CV GrandRounds. Wonderful connecting w old friends, making new ones, &amp; connecting w <a href="/UVACardsFellows/">UVA Cardiology Fellowship</a>. Look forward to further collaborations. Despite the ⛈️, Zocalo was awesome!😄<a href="/ChrisKramerMD/">Christopher Kramer MD</a> <a href="/AbbateAntonio/">AntonioAbbate</a>
Behnood Bikdeli (@bbikdeli) 's Twitter Profile Photo

Need to do better for #PE risk stratification, beyond reductionist models. In an European Society of Cardiology Journals #EHJ paper we show that a multimarker calculator🌡️outperforms the ESC model. Great work by David Jiménez 🇪🇸 manuel monreal et al #RIETE! Honored to be a part of it 👇: tinyurl.com/trpmzbrd

Need to do better for #PE risk stratification, beyond reductionist models. In an <a href="/ESC_Journals/">European Society of Cardiology Journals</a> #EHJ paper we show that a multimarker  calculator🌡️outperforms the ESC model. Great work by <a href="/DJC6998/">David Jiménez 🇪🇸</a> <a href="/mmonrealriete/">manuel monreal</a> et al #RIETE! Honored to be a part of it 👇:
 tinyurl.com/trpmzbrd
Pradeep Natarajan (@pnatarajanmd) 's Twitter Profile Photo

Among 889 with colon cancer s/p resection & adjuvant chemotherapy, RCT shows that a 3y structured exercise program vs health education alone showed 28% relative improvement in disease-free survival at 7.9y nejm.org/doi/full/10.10… NEJM (coverage nytimes.com/2025/06/01/wel…

Vasculearn Network (@vasculearn) 's Twitter Profile Photo

🌞 June is here, bringing warmer weather and something else that's "hot"... our June edition of What's Hot In Clots, of course! Here's a quick look at some intriguing updates in cardiovascular and thrombotic care this month: 🔹 Intraprocedural ACT Targets in PCI: Do we finally

🌞 June is here, bringing warmer weather and something else that's "hot"... our June edition of What's Hot In Clots, of course!

Here's a quick look at some intriguing updates in cardiovascular and thrombotic care this month:

🔹 Intraprocedural ACT Targets in PCI: Do we finally
Raja-Elie Abdulnour (@bagelemage) 's Twitter Profile Photo

Not unexpected. LLMs can help us write discharge summaries. Let’s make sure clinicians help shape their implementation and ensure a patient-first innovation.

JACC Journals (@jaccjournals) 's Twitter Profile Photo

Antiplatelet or anticoagulant? The new ACS guideline decodes the chaos with clarity. A must-read roadmap for frontline care 🧭 jacc.org/doi/10.1016/j.… #JACC #cvACS #ClinicalGuidelines Dr Roxana Mehran David J. Cohen, MD, MSc Behnood Bikdeli Harlan Krumholz

Antiplatelet or anticoagulant? The new ACS guideline decodes the chaos with clarity. A must-read roadmap for frontline care 🧭 jacc.org/doi/10.1016/j.…

#JACC #cvACS #ClinicalGuidelines <a href="/Drroxmehran/">Dr Roxana Mehran</a> <a href="/djc795/">David J. Cohen, MD, MSc</a> <a href="/bbikdeli/">Behnood Bikdeli</a> <a href="/hmkyale/">Harlan Krumholz</a>
Vasculearn Network (@vasculearn) 's Twitter Profile Photo

💜 How we talk about blood clots matters. 💜 🏥 The VTE Communication Guide was created to help clinicians navigate the complex conversations that follow a venous thromboembolism (VTE) diagnosis from risk and treatment to emotions and uncertainty. ❤️ This project brings

💜 How we talk about blood clots matters. 💜 

🏥 The VTE Communication Guide was created to help clinicians navigate the complex conversations that follow a venous thromboembolism (VTE) diagnosis from risk and treatment to emotions and uncertainty.   

❤️ This project brings